By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > ACE inhibitor > Trandolapril

Trandolapril

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|644 words

Trandolapril Drug Profile

What is Trandolapril?

Trandolapril is a prescription medication belonging to a class of drugs called ACE (angiotensin-converting enzyme) inhibitors. It is primarily used to treat high blood pressure and heart failure by helping blood vessels relax and widen. This medication is taken orally and works by blocking an enzyme that causes blood vessels to narrow.

Uses

Trandolapril is approved for several cardiovascular conditions:

  • Hypertension (High Blood Pressure): Used as a first-line treatment to lower blood pressure and reduce the risk of stroke, heart attack, and kidney problems
  • Heart Failure: Helps improve symptoms and survival in patients with reduced heart function by decreasing the workload on the heart
  • Post-Heart Attack Treatment: Prescribed to patients who have survived a heart attack to prevent further cardiovascular events and improve long-term outcomes
  • Diabetic Kidney Disease: May be used to slow the progression of kidney damage in diabetic patients with high blood pressure
  • Cardiovascular Risk Reduction: Prescribed for patients at high risk of heart disease to prevent future cardiovascular events

How it works

Trandolapril works by blocking the angiotensin-converting enzyme (ACE), which normally converts angiotensin I to angiotensin II, a powerful substance that causes blood vessels to constrict. By inhibiting this enzyme, trandolapril allows blood vessels to remain relaxed and dilated, reducing blood pressure and decreasing the heart’s workload. Additionally, it reduces the breakdown of bradykinin, a substance that also helps keep blood vessels open.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Dry, persistent cough
  • Dizziness or lightheadedness
  • Fatigue or weakness
  • Headache
  • Nausea or stomach upset
  • Low blood pressure
  • Elevated potassium levels
  • Skin rash

Serious side effects requiring immediate medical attention:

  • Angioedema (swelling of face, lips, tongue, or throat)
  • Severe kidney problems or kidney failure
  • Dangerously high potassium levels
  • Severe allergic reactions
  • Liver dysfunction

Warnings and precautions

  • Pregnancy: Trandolapril is contraindicated during pregnancy, especially in the second and third trimesters, as it can cause serious harm or death to the developing fetus
  • Kidney disease: Patients with severe kidney disease or those on dialysis should use this medication with extreme caution, as it can worsen kidney function
  • Angioedema history: Individuals with a previous history of angioedema should not take trandolapril due to increased risk of life-threatening swelling
  • Dehydration: Patients who are dehydrated, have low sodium levels, or are taking diuretics may experience dangerous drops in blood pressure
  • Liver impairment: Those with liver disease may need dose adjustments, as the medication is processed by the liver

Interactions

  • Potassium supplements and salt substitutes: Can cause dangerously high potassium levels when combined with trandolapril
  • Diuretics: May increase the risk of low blood pressure, especially when starting treatment
  • NSAIDs (ibuprofen, naproxen): Can reduce the effectiveness of trandolapril and increase kidney damage risk
  • Lithium: Trandolapril may increase lithium levels in the blood, leading to toxicity
  • Diabetes medications: ACE inhibitors may enhance the blood sugar-lowering effects of diabetes drugs
  • Other blood pressure medications: Combined use may cause excessive blood pressure reduction
  • Aliskiren: Should be avoided in patients with diabetes or kidney disease due to increased risk of complications
  • Gold injections: May cause severe reactions when used with ACE inhibitors

Check interactions with the GMJ Interaction Checker

Dosage

The typical starting dose for adults with hypertension is 1-2 mg once daily, which may be increased gradually to a maintenance dose of 2-4 mg daily based on blood pressure response. For heart failure, the starting dose is usually 1 mg daily, potentially increased to 4 mg daily as tolerated. Patients with kidney or liver impairment may require lower doses. The maximum recommended dose is generally 8 mg daily. Dosage adjustments should always be made under medical supervision, and patients should take the medication at the same time each day, with or without food.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Trandolapril." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/trandolapril-2/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Quinapril

By
GMJ News Desk
01/06/2026

Captopril

By
GMJ News Desk
01/06/2026

Benazepril

By
GMJ News Desk
01/06/2026

Fosinopril

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up